Healthtech funding in Q2 2026
European Healthtech startup funding raised during Q2 2026.
In Q2 2026, 102 European Healthtech companies closed 104 funding rounds and raised €2.7B in equity funding (excluding debt and grants), up 86.0% versus Q2 2025. Debt rounds added €32M. UK led by capital raised, and High-Tech Gründerfonds (HTGF) was the most active investor. Data as of 20 Nov 2026.
Equity funding
€2.7B
+86.0% vs Q2 2025 · excl. debt & grants · +€32M debt
Funding rounds
104
-18.1% vs Q2 2025
Companies
102
Top country
UK
Rank among sectors
#3
11.0% of sector funding
Debt financing
€32M
1.2% of total
Top-10 round share
81.3%
of disclosed capital
Rounds ≥ €100M
1
Funding by month
€ raised vs rounds, by monthHealthtech — funding by month, Q2 2026 — interactive chart.
Data table
| Funding | Rounds | |
|---|---|---|
| Apr | €253M | 35 |
| May | €2.0B | 33 |
| Jun | €486M | 36 |
Top countries
by € raisedHealthtech — top countries by capital, Q2 2026 — interactive chart.
Data table
| Healthtech — top countries by capital, Q2 2026 | |
|---|---|
| UK | €2.1B |
| France | €161M |
| Switzerland | €137M |
| Spain | €124M |
| Germany | €118M |
| Netherlands | €50M |
| Sweden | €31M |
| Italy | €17M |
Stage mix
by € raisedHealthtech — stage mix, Q2 2026 — interactive chart.
Data table
| Healthtech — stage mix, Q2 2026 | |
|---|---|
| Series B | €1.9B |
| Other | €301M |
| Series A | €155M |
| Seed | €95M |
| Series D+ | €86M |
| Series C | €82M |
| Growth/Late | €52M |
| Debt | €32M |
| Pre-Seed | €15M |
| Grant | €5.0M |
| Crowdfunding | €233k |
Top deals
largest disclosed rounds in Q2 2026| Company | Stage | Date | Amount |
|---|---|---|---|
| Isomorphic Labs | Series B | May 2026 | €1.8B |
| CeQur | Series D+ | Jun 2026 | €86M |
| Ona Therapeutics | Series B | Jun 2026 | €74M |
| Uromems | Growth/Late | May 2026 | €52M |
| Storm Therapeutics | Series C | Apr 2026 | €48M |
| NVision Imaging | Series B | May 2026 | €47M |
| IMU Biosciences | Other | Jun 2026 | €45M |
| Leyden Labs | Other | Jun 2026 | €40M |
| Semble | Series C | Jun 2026 | €35M |
| Tissium | Other | Jun 2026 | €30M |
| Tissium | Debt | Jun 2026 | €30M |
| NUCLIDIUM | Series B | May 2026 | €29M |
| Prosper AI | Series A | Jun 2026 | €26M |
| Lightcast Discovery | Other | Apr 2026 | €23M |
| EnteroBiotix | Other | May 2026 | €22M |
Top investors
most active in Q2 2026, by deal count- High-Tech Gründerfonds (HTGF)5 deals
- better ventures4 deals
- Angelini Ventures3 deals
- Bayern Kapital3 deals
- Grazia Equity3 deals
- NRW.BANK3 deals
- Octopus Ventures3 deals
- Redalpine3 deals
- Singular3 deals
- 3TS Capital Partners2 deals